March 24 (Reuters) - Werewolf Therapeutics Inc HOWL.O :
* WEREWOLF THERAPEUTICS REPORTS FOURTH QUARTER 2021 AND FULL
YEAR
2021 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
* WEREWOLF THERAPEUTICS - EXPECTS EXISTING CASH, EQUIVALENTS
TO
ENABLE FUNDING OF OPERATING EXPENSES AND CAPEX NEEDS THROUGH AT
LEAST Q2 OF 2023
* QTRLY LOSS PER SHARE $0.66
* Q4 EARNINGS PER SHARE VIEW $-0.53 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX86v4lJ
Further company coverage: HOWL.O
((Reuters.Briefs@thomsonreuters.com;))